| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/GAST.2001.27124 |
| P698 | PubMed publication ID | 11522752 |
| P50 | author | Johannes-Matthias Löhr | Q49338331 |
| Thomas Gress | Q59785425 | ||
| P2093 | author name string | G Adler | |
| S Tsukita | |||
| P Michl | |||
| M Buchholz | |||
| S Kunsch | |||
| G Leder | |||
| M Rolke | |||
| B McClane | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| Clostridium perfringens | Q309465 | ||
| P304 | page(s) | 678-684 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin | |
| P478 | volume | 121 |
| Q33826108 | A novel screening system for claudin binder using baculoviral display |
| Q89077427 | Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer |
| Q59019210 | Amino-Functionalized Silica Nanoparticles: In Vitro Evaluation for Targeted Delivery and Therapy of Pancreatic Cancer |
| Q37717794 | Bacteria in cancer therapy: a novel experimental strategy |
| Q39094451 | Bacterial Toxins for Oncoleaking Suicidal Cancer Gene Therapy |
| Q57457697 | CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro |
| Q53344716 | Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma. |
| Q80565374 | Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions |
| Q37611453 | Claudin and ovarian cancer |
| Q54646160 | Claudin expression in Barrett's esophagus and adenocarcinoma. |
| Q34640575 | Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas |
| Q30491616 | Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response |
| Q38761851 | Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway |
| Q40355382 | Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas |
| Q39491260 | Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma |
| Q39489740 | Claudin-4 overexpression is associated with epigenetic derepression in gastric carcinoma. |
| Q39335167 | Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions |
| Q39527898 | Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer |
| Q36438309 | Claudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancer |
| Q44696681 | Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype |
| Q38110750 | Claudins and other tight junction proteins |
| Q35769832 | Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura |
| Q26851347 | Claudins overexpression in ovarian cancer: potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy |
| Q50750848 | Claudins upregulation in human colorectal cancer. |
| Q36967957 | Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis. |
| Q37028913 | Clinicopathological significance of claudin-4 in gastric carcinoma |
| Q37613674 | Clostridial toxins |
| Q26752971 | Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications |
| Q35564030 | Clostridium perfringens enterotoxin (CPE) and CPE-binding domain (c-CPE) for the detection and treatment of gynecologic cancers |
| Q35659378 | Clostridium perfringens enterotoxin C-terminal domain labeled to fluorescent dyes for in vivo visualization of micrometastatic chemotherapy-resistant ovarian cancer |
| Q33624175 | Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer |
| Q35098046 | Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. |
| Q89736885 | Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas |
| Q27005742 | Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapy |
| Q52901579 | Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett’s esophagus |
| Q40257166 | DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma. |
| Q33442189 | Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas |
| Q53264168 | Differences in expression patterns of the tight junction proteins,claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours. |
| Q61773593 | Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12 |
| Q56836339 | Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy |
| Q43230104 | Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas |
| Q38726540 | Dual-Targeting Nanoparticles for In Vivo Delivery of Suicide Genes to Chemotherapy-Resistant Ovarian Cancer Cells |
| Q26765201 | Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalk |
| Q36216216 | Effect of Heat-Inactivated Clostridium sporogenes and Its Conditioned Media on 3-Dimensional Colorectal Cancer Cell Models |
| Q39542097 | Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells |
| Q37225107 | Emerging roles of claudins in human cancer |
| Q37970075 | Enterocytes' tight junctions: From molecules to diseases |
| Q36983929 | Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin |
| Q28185685 | Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays |
| Q39628515 | Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas. |
| Q42440831 | Expression of tight junction protein claudin-4 in basal-like breast carcinomas. |
| Q35115628 | Gene Expression in Neoplasms of the Pancreas: Applications to Diagnostic Pathology |
| Q36616750 | Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy |
| Q35094629 | Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas |
| Q24800194 | Genetic abnormalities in pancreatic cancer |
| Q34194569 | Helicobacter pylori activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability |
| Q46640779 | Hemagglutinin protease secreted by V. cholerae induced apoptosis in breast cancer cells by ROS mediated intrinsic pathway and regresses tumor growth in mice model |
| Q33557833 | Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin |
| Q36858042 | Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer |
| Q47104566 | Identification of claudin-4 binder that attenuates tight junction barrier function by TR-FRET-based screening assay |
| Q24299968 | Identification of novel VHL target genes and relationship to hypoxic response pathways |
| Q89338409 | Immunoreactivity patterns of tight junction proteins are useful for differential diagnosis of human salivary gland tumors |
| Q54440368 | Improvement of malignant serous effusions diagnosis by quantitative analysis of molecular claudin 4 expression. |
| Q42476044 | Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia |
| Q37377308 | Longitudinal Claudin Gene Expression Analyses in Canine Mammary Tissues and Thereof Derived Primary Cultures and Cell Lines |
| Q92899999 | LukS-PV induces apoptosis in acute myeloid leukemia cells mediated by C5a receptor |
| Q64890641 | MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature. |
| Q34082610 | MicroRNA alterations of pancreatic intraepithelial neoplasias |
| Q30393523 | Molecular Imaging of Pancreatic Cancer with Antibodies |
| Q36485336 | Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts |
| Q37196543 | Molecular target therapies in endometrial cancer: from the basic research to the clinic. |
| Q40234364 | Na-K-ATPase regulates tight junction permeability through occludin phosphorylation in pancreatic epithelial cells |
| Q41447334 | Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. |
| Q39462845 | Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors |
| Q37954298 | On the interaction of Clostridium perfringens enterotoxin with claudins |
| Q53568876 | Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE). |
| Q90710469 | Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease |
| Q38522757 | Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis. |
| Q26787279 | Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis |
| Q36082365 | Phosphorylation of claudin-4 by PKCepsilon regulates tight junction barrier function in ovarian cancer cells |
| Q92703058 | Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1 |
| Q38021496 | Proof of concept for claudin-targeted drug development |
| Q39429708 | Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. |
| Q35965742 | Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots |
| Q36279105 | Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy |
| Q37423257 | Regulation and roles for claudin-family tight junction proteins |
| Q39336324 | Regulation of tight junctions in human normal pancreatic duct epithelial cells and cancer cells |
| Q38091094 | Regulation of tight junctions in upper airway epithelium |
| Q38594976 | Role of tight junctions in signal transduction: an update. |
| Q38821198 | Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers |
| Q27027759 | SIBLINGs and SPARC families: their emerging roles in pancreatic cancer |
| Q36817494 | Screening for genes and subnetworks associated with pancreatic cancer based on the gene expression profile |
| Q34221837 | Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin |
| Q37295746 | Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis |
| Q35155903 | Specificity of interaction between clostridium perfringens enterotoxin and claudin-family tight junction proteins |
| Q37156702 | Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma |
| Q27648943 | Structure of the claudin-binding domain of Clostridium perfringens enterotoxin |
| Q36685675 | Target discovery and validation in pancreatic cancer |
| Q33464353 | Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin |
| Q39013776 | Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin |
| Q64089708 | Targeting claudin-4 enhances CDDP-chemosensitivity in gastric cancer |
| Q89840285 | Targeting claudin-4 enhances chemosensitivity in breast cancer |
| Q93194999 | Targeting claudin-4 enhances chemosensitivity of pancreatic ductal carcinomas |
| Q38026601 | Targeting claudin-4 in human pancreatic cancer |
| Q91873340 | Targeting claudin-overexpressing thyroid and lung cancer by modified Clostridium perfringens enterotoxin |
| Q38242808 | Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer. |
| Q37302556 | The claudin family of proteins in human malignancy: a clinical perspective |
| Q21260426 | The claudin gene family: expression in normal and neoplastic tissues |
| Q38811256 | The interaction of Clostridium perfringens enterotoxin with receptor claudins |
| Q35801829 | The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians |
| Q38927656 | The role of claudins in cancer metastasis |
| Q38077200 | Tight junction-related human diseases |
| Q37139446 | Tight junctions and the modulation of barrier function in disease |
| Q27012318 | Tight junctions in human pancreatic duct epithelial cells |
| Q37420725 | Tight junctions: a barrier to the initiation and progression of breast cancer? |
| Q40046453 | Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells |
| Q34033442 | Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells |
| Q39580311 | Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells |
| Q38957238 | Universal antibody conjugation to nanoparticles using the Fcγ receptor I (FcγRI): quantitative profiling of membrane biomarkers |
| Q35215182 | Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: Opportunities and Challenges |
| Q91738818 | Zinc finger protein 703 induces EMT and sorafenib resistance in hepatocellular carcinoma by transactivating CLDN4 expression |
Search more.